HCL Tech Q4 dollar revenue disappoints investors, shares fall

MUMBAI Thu Jul 31, 2014 3:58pm IST

Workers are seen at their workstations on the floor of an outsourcing centre in Bangalore, February 29, 2012. REUTERS/Vivek Prakash/Files

Workers are seen at their workstations on the floor of an outsourcing centre in Bangalore, February 29, 2012.

Credit: Reuters/Vivek Prakash/Files

Related Topics

Stocks

   

MUMBAI (Reuters) - HCL Technologies Ltd (HCLT.NS), India's fourth-largest IT services exporter, reported on Thursday quarterly growth in its dollar-denominated revenue that missed analyst estimates, sending the company's shares down by as much as 2.5 percent.

For most IT services companies, analysts and investors track the dollar sales numbers as clients oversees get billed in that currency. For the quarter ended June, HCL posted a 3.4 percent rise from March to $1.4 billion, below industry leader Tata Consultancy Services' (TCS) (TCS.NS) 5.5 percent increase.

"We were expecting it to grow about 4 percent. In the past HCL has been able to keep at about the same dollar revenue growth as TCS," said Ankita Somani, analyst at brokerage MSFL Research.

HCL is part of a $108 billion Indian outsourcing sector that generate the lion's part of their sales by providing services like IT network installation and development of software applications to Western clients.

Revenue from the Americas, HCL's largest market, saw a rise of 12 percent in the quarter, while sales in Europe, where the company's clients include a British government agency and a Swiss pharmaceutical company, rose 25 percent.

Consolidated net profit in its fiscal fourth-quarter ended June 30 rose 54 percent to 18.34 billion rupees ($305.4 million) from 11.93 billion rupees a year earlier, the company said.

Analysts, on average, had expected the company to report a net profit of 16.15 billion rupees.

HCL shares closed 2.7 percent lower at 1,555.10 rupees.

Research firm Gartner says global IT spending is expected to total $3.7 trillion in 2014, up 2.1 percent from a year earlier.

($1 = 60.0600 rupees)

(Reporting by Devidutta Tripathy and Nivedita Bhattacharjee; Editing by Ryan Woo)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Drug Pricing

REUTERS SHOWCASE

Modi Speaks

Modi Speaks

PM Modi says al Qaeda will fail in India - CNN.  Full Article 

Alibaba Listing

Alibaba Listing

Alibaba surges on massive demand in trading debut  Full Article 

Importing Rice

Importing Rice

Top rice exporter India importing over 100,000 T on temporary supply squeeze.  Full Article 

GSK Fined

GSK Fined

China hands drugmaker GSK record $489 mln fine, sentences executives.  Full Article 

HMT in Demand

HMT in Demand

Fans rush to HMT as watchmaker marks time.  Full Article 

Apple Not Cool?

Apple Not Cool?

Some consumers say Apple is losing its "cool" factor  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage